Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-25-003612
Filing Date
2025-05-13
Accepted
2025-05-13 15:31:04
Documents
62
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nexalintechno_10q.htm   iXBRL 10-Q 800822
2 EXHIBIT 31.1 nexalintechno_ex31-1.htm EX-31.1 11115
3 EXHIBIT 32.1 nexalintechno_ex32-1.htm EX-32.1 5165
  Complete submission text file 0001829126-25-003612.txt   4949135

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nxl-20250331.xsd EX-101.SCH 35123
5 XBRL CALCULATION FILE nxl-20250331_cal.xml EX-101.CAL 44806
6 XBRL DEFINITION FILE nxl-20250331_def.xml EX-101.DEF 156740
7 XBRL LABEL FILE nxl-20250331_lab.xml EX-101.LAB 301911
8 XBRL PRESENTATION FILE nxl-20250331_pre.xml EX-101.PRE 262199
64 EXTRACTED XBRL INSTANCE DOCUMENT nexalintechno_10q_htm.xml XML 757400
Mailing Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056
Business Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056 (832) 260-0222
Nexalin Technology, Inc. (Filer) CIK: 0001527352 (see all company filings)

EIN.: 275566468 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41507 | Film No.: 25939510
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)